Explain this page
Arphra AIPlain-English read on Astera Labs, Inc. Common Stock’s valuationIncome statement
| In USD | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|
| Revenue & profit | ||||||||
| Revenue | $79.87M | $115.79M | $396.29M | $852.53M | $1.55B | $2.21B | $2.79B | $2.62B |
| Cost of revenue | $21.19M | $35.97M | $93.59M | $207.26M | $406.84M | $565.16M | $752.54M | $679.04M |
| Gross profit | $58.68M | $79.83M | $302.7M | $645.26M | $1.16B | $1.6B | $2.02B | $1.9B |
| Gross margin | +73.47% | +68.94% | +76.38% | +75.69% | +75.31% | +72.47% | +72.59% | +72.54% |
| Operating | ||||||||
| Research & development | $73.71M | $73.41M | $200.83M | $304M | $762.82M | $1.11B | $1.36B | $1.32B |
| Selling, general & administrative | $45.16M | $35.92M | $217.94M | $167.84M | $558.82M | $781.14M | $957.6M | $899.31M |
| Total operating expenses | $118.88M | $109.32M | $418.77M | $471.84M | $1.34B | $1.88B | $2.31B | $2.18B |
| Operating income | -$60.19M | -$29.5M | -$116.07M | $173.42M | -$173.55M | -$254.84M | -$322.41M | -$306.23M |
| Operating margin | -75.36% | -25.47% | -29.29% | +20.34% | -11.22% | -11.54% | -11.57% | -11.67% |
| EBITDA | -$59.39M | -$27.72M | -$112.91M | $224.98M | -$134.93M | -$197.42M | -$247.17M | -$228.9M |
| EBIT | -$60.19M | -$29.5M | -$116.07M | $218.15M | -$151.55M | -$216.91M | -$278.43M | -$257.78M |
| Below the line | ||||||||
| Interest expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest income | $2.61M | $6.55M | $34.29M | $44.73M | $99.47M | $140.51M | $181.23M | $171.11M |
| Other income / expense | $2.61M | $6.55M | $34.29M | $44.73M | — | — | — | — |
| Pre-tax income | -$57.58M | -$22.95M | -$81.78M | $218.15M | -$76.66M | -$111.62M | -$140.42M | -$129.82M |
| Income tax expense | $764K | $3.31M | $1.64M | -$981K | $337.08K | $498.12K | $623.96K | $569.33K |
| Earnings | ||||||||
| Net income | -$58.35M | -$26.26M | -$83.42M | $219.13M | -$94.46M | -$135.71M | -$164.08M | -$157.08M |
| Net income · continuing ops | -$58.35M | -$26.26M | -$83.42M | $219.13M | -$94.92M | -$133.27M | -$165.71M | -$156.49M |
| Net margin | -73.05% | -22.68% | -21.05% | +25.70% | -6.11% | -6.14% | -5.89% | -5.99% |
| EPS · basic | $-0.45 | $-0.17 | $-0.64 | $1.32 | $3.09 | $4.48 | $5.87 | $5.33 |
| EPS · diluted | $-0.45 | $-0.17 | $-0.64 | $1.22 | $2.97 | $4.30 | $5.66 | $5.26 |
| EPS · low estimate | — | — | — | — | $2.80 | $3.27 | $3.06 | $4.64 |
| EPS · high estimate | — | — | — | — | $3.29 | $6.39 | $9.41 | $7.23 |
| Shares · basic | 130.45M | 152.5M | 131.26M | 166.41M | 164.77M | 166.72M | 165.57M | 166.04M |
| Shares · diluted | 130.45M | 152.5M | 131.26M | 179.55M | 178.98M | 178.29M | 180.24M | 177.96M |
| Coverage | ||||||||
| Analysts (revenue) | — | — | — | — | 18 | 18 | 15 | 11 |
| Analysts (EPS) | — | — | — | — | 15 | 14 | 9 | 3 |
Coverage notes. Historical figures come’s as-reported income statements / balance sheets / cash flows in our data warehouse. Forecast columns (italicised, faint accent tint) carry vendor-supplied numbers where available (revenue + EPS consensus) and ratio-derived values for every other line. Margins / ratios are the trailing-3y average from history applied to the forecast revenue; values are clamped to enforce P&L identity (gross ≥ operating, EBITDA ≥ operating, net ≤ operating) and balance-sheet identity (assets = liabilities + equity by construction). Cash-flow FCF reconciles to OCF + CapEx. USD conversion uses the period-end close of the issuer's reported/USD pair from forex_prices_daily; share counts stay unconverted.
Financials
Full income statement, balance sheet, and cash-flow history is included with Pro.
Upgrade to Pro